Beech Hill Advisors, Inc. Takeda Pharmaceutical CO LTD Transaction History

Beech Hill Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$13.17 - $16.4 $342,420 - $426,399	-26,000 Closed	0 $0
Q3 2021 Oct 14, 2021	SELL	$16.3 - $17.26 $130,400 - $138,080	-8,000 Reduced 23.53%	26,000 $426,000
Q2 2021 Jul 15, 2021	SELL	$16.55 - $18.64 $33,100 - $37,280	-2,000 Reduced 5.56%	34,000 $572,000
Q1 2021 Apr 19, 2021	BUY	$16.71 - $19.9 $601,560 - $716,400	36,000 New	36,000 $657,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Beech Hill Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Beech Hill Advisors, Inc. with notifications on news.